occurs in has participant quality has disease treated with drug Propafenone [Chemical/Ingredient] Sumatriptan [Chemical/Ingredient] Nalidixic Acid [Chemical/Ingredient] INTERFERON ALFA-2A ZOLPIDEM VENLAFAXINE ROPINIROLE CLOPIDOGREL ATAZANAVIR ESZOPICLONE PREGABALIN INDOMETHACIN ENALAPRIL MALEATE AMIODARONE HYDROCHLORIDE CYTARABINE LEUPROLIDE ACETATE CIPROFLOXACIN HYDROCHLORIDE LISINOPRIL NORFLOXACIN RAMIPRIL AMANTADINE BETAXOLOL BUPROPION BUSPIRONE CLOMIPRAMINE DOXORUBICIN FLECAINIDE MEFLOQUINE METHOTREXATE SELEGILINE TOLMETIN LOMEFLOXACIN SOTALOL PAROXETINE LOSARTAN POTASSIUM LANSOPRAZOLE RITONAVIR LEVOFLOXACIN ZOLMITRIPTAN TOLCAPONE LEFLUNOMIDE EFAVIRENZ THALIDOMIDE TRASTUZUMAB ROFECOXIB SIROLIMUS ZALEPLON MOXIFLOXACIN PANTOPRAZOLE LINEZOLID ZONISAMIDE ZIPRASIDONE ALMOTRIPTAN VALDECOXIB ELETRIPTAN GEMIFLOXACIN EMTRICITABINE VARDENAFIL MEMANTINE DAPTOMYCIN TINIDAZOLE LENALIDOMIDE TELBIVUDINE MARAVIROC CABAZITAXEL sinusitis EAST syndrome heart conduction disease prostate cancer hypertension obsessive-compulsive disorder lymphocytic choriomeningitis malaria dementia acute cystitis peptic esophagitis Parkinson's disease prostatitis major depressive disorder breast cancer cancer duodenal ulcer impotence hepatitis C trichomoniasis anxiety disorder hepatitis B ovarian cancer hairy cell leukemia endometriosis bipolar disorder lymphangioleiomyomatosis human immunodeficiency virus infectious disease sleep disorder schizophrenia pneumonia peripheral nervous system disease congestive heart failure bronchitis migraine rheumatoid arthritis gonorrhea osteoarthritis influenza chronic myeloid leukemia bacterial pneumonia intermediate coronary syndrome Ritter's disease multiple myeloma Elderly Child Adult Adolescent dizziness AE 10013573 HPO: HP_0002321 a sensory capability AE that has an outcome of dizziness Dizziness describes a number of subjective symptoms, which the patient may describe as feelings of lightheadedness, floating, wooziness, giddiness, confusion, disorientation or loss of balance. Medical terms include vertigo, disequilibrium, pre-syncope or syncoptic episode. Causes may stem from a variety of failures of equilibrioception, hypotension, cerebral hypoxia or a reaction to environmental chemicals or drugs. CTCAE:E12631 SIDER: C0012833 YH, SS, MW NCIt:C37943 sensory capability AE AE severity G1 AE severity G2 AE severity G3